Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Puma, but not noxa is essential for oligodendroglial cell death.
[Infections and fingolimod].
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Double blind placebo-controlled Phase I/II clinical trial of idebenone in patients with primary progressive multiple sclerosis (IPPoMS)
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with MS.
Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Calcitriol Modulates the CD46 Pathway in T Cells.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Generic Midamor
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
Pages
« first
‹ previous
…
95
96
97
98
99
100
101
102
103
…
next ›
last »